Schrodinger SDGR 深 滬
等待開盤 09-25 09:30:00 美东时间
19.06
0.000
0.00%
華盛通- 最 高19.4225
- 今 開19.06
- 成交量 72.95万股
- 最 低 18.8909
- 昨 收 19.06
- 總市值 13.99亿
- 52周最高 28.47
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 16.6016
- 委 比 -63.91%
- 總股本 7337.69万
- 歷史最高 117.00
- 量 比 0.62
- 振 幅 2.79%
- 歷史最低 15.85
- 每 手 1
- 風險率 2.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Craig-Hallum Reaffirms Their Buy Rating on Schrodinger (SDGR)
Craig-Hallum analyst Matt Hewitt reiterated a Buy rating on Schrodinger on Sept...
09-21 16:25
启明星 | 启明创投毛硕入选2025年中U40杰出青年投资人榜单
日前，企名片发布2025年中U40杰出青年投资人榜单，以鼓励所有具备敏锐眼光和强专业能力的青年从业者。 启明创投执行董事毛硕入选榜单。 启明创投执...
09-12 11:09
Schrodinger Announces CFO Geoffrey Porges’ Departure
The latest announcement is out from Schrodinger ( ($SDGR) ). On September 5, 20...
09-09 04:49
An Overview of Phreesia's Earnings
Phreesia (NYSE:PHR) is preparing to release its quarterly earnings on Thursday,...
09-03 23:02
What 4 Analyst Ratings Have To Say About Schrodinger
Schrodinger (NASDAQ:SDGR) underwent analysis by 4 analysts in the last quarter,...
08-19 05:03
This Cisco Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a comple...
08-15 22:53
Schrodinger downgraded at Citi after clinical program exit
Citi downgraded Schrodinger (NASDAQ:SDGR) to Neutral from Buy after the AI-focused biotech announced its decision to discontinue a clinical program for a leukemia candidate following the emergence of ...
08-15 19:47
Schrodinger drops 16% as it abandons leukemia candidate
Schrodinger (NASDAQ:SDGR) has fallen ~16% in premarket trading Thursday after announcing it would end development of SGR-2921 for relapsed/refractory acute myeloid leukemia or high-risk myelodysplasti...
08-14 20:55
Barclays Initiates Coverage On Schrodinger with Overweight Rating, Announces Price Target of $25
Barclays analyst Peter Lawson initiates coverage on Schrodinger (NASDAQ:SDGR) with a Overweight rating and announces Price Target of $25.
08-14 18:48
